RT Journal Article
SR Electronic
T1 Sleep disorders as risk factors for calcific aortic stenosis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.15.24317390
DO 10.1101/2024.11.15.24317390
A1 El Jamal, Nadim
A1 Brooks, Thomas G.
A1 Skarke, Carsten
A1 FitzGerald, Garret A.
YR 2024
UL http://medrxiv.org/content/early/2024/11/15/2024.11.15.24317390.abstract
AB Background Circadian disruption and sleep disorders have been shown to increase the risk for many cardiovascular diseases. Their association specifically with valvular heart disease, however, is inconclusive.Methods We leveraged large electronic health record datasets (the TriNetX network and the All of Us study) to test whether sleep disorders are a risk factor for calcific aortic stenosis (AS). We fitted Cox proportional hazards models to quantify the risk of future incidence of AS in patients with sleep disorders. We also explored clinical laboratory test datasets for biochemical signals that might explain the association, running mediation analyses.Results In our fully adjusted Cox models, we find that having any sleep disorder increases the risk for the future incidence of AS (HR: 1.15 95% CI: 1.13-1.18). Changes in lipid profile mediate a proportion of that association.Conclusion Sleep disorders are associated with an increased risk of AS incidence. That association is independent of classical cardiovascular risk factors even though dyslipidemia plays a large role in mediating this risk.Competing Interest StatementG.A. FitzGerald is the McNeil Professor of Translational Medicine and Therapeutics and held a Merit Award from the American Heart Association (17MERIT33560013) during the performance of this work. He is Senior Advisor at Calico Laboratories. C. Skarke is the Robert L. McNeil Jr. Fellow in Translational Medicine and Therapeutics. The other authors report no conflicts.Funding StatementG.A. FitzGerald is the McNeil Professor of Translational Medicine and Therapeutics and held a Merit Award from the American Heart Association (17MERIT33560013) during the performance of this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board at the University of Pennsylvania waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data used in this study are available by applying for access from the TriNetX network and the All of Us study.